Theseus Pharmaceuticals, Inc is a biopharmaceutical company based in Cambridge, MA, dedicated to revolutionizing cancer treatment by developing next-generation tyrosine kinase inhibitors (TKIs) to combat treatment resistance. Their targeted, small molecule therapies are designed to address the challenges posed by cancer resistance, offering hope to patients in need.
With a focus on delivering best-in-class pan-variant TKIs, Theseus Pharmaceuticals is developing a robust pipeline of therapies that target major cancer-causing and drug resistance mutations in clinically significant tyrosine kinase targets. Their mission is to outsmart cancer resistance and transform the way cancer is treated, offering new possibilities for patients and healthcare providers alike.
Generated from the website